Authors' objectives:

To summarize the available information on the nitric oxide (NO) measurement system (trademarked NIOX) for monitoring response to asthma treatment, manufactured by Aerocrine AB, Stockholm, Sweden.

Authors' recommendations: NIOX is another option for the clinical assessment of patient compliance and response to medication. It has advantages over some other methods in that it is linked to the extent of airway inflammation. The device can be used by children over the age of four. Because it is a high-cost device, NIOX might be most commonly used in clinics or practices with large numbers of patients with asthma. The measurement of exhaled NO is also being investigated for applications in chronic obstructive pulmonary disease, cystic fibrosis, and chronic cough. No information was found on the extent to which the use of this device improves patient compliance with medication use or ensures appropriate prescribing. Comparative studies to obtain such measures of efficacy would be desirable.

Authors' methods: Overview

Project Status: Completed

URL for project: https://www.ccohta.ca/

Year Published: 2004

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Canadian Coordinating Office for Health Technology Assessment

Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;

Contact Name: requests@cadth.ca

Contact Email: requests@cadth.ca

Copyright: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)